Company · CIK 0001690585
Dianthus Therapeutics, Inc. /DE/
DNTHSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$82.43−$2.45 (−2.89%)
DNTH · Last trade
- Prev close
- $84.88
- Range (29d)
- $82.43 – $107.69
On the record
Recent filings
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-009619 · 4.8 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-008950 · 4.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/ADNTHDianthus Therapeutics, Inc. /DE/0000919574-26-005203 · 11.2 KBSEC(opens sec.gov)
- SCHEDULE 13GDNTHDianthus Therapeutics, Inc. /DE/0000902219-26-000243 · 17.3 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-007911 · 6.3 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001974158-26-000096 · 4.7 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-007887 · 4.9 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-007814 · 5.0 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-007811 · 5.6 KBSEC(opens sec.gov)
- 144DNTHDianthus Therapeutics, Inc. /DE/0001950047-26-007793 · 4.8 KBSEC(opens sec.gov)
Insiders
- Albers Jeffrey W.Director
- Alphabet Inc.10% Owner
- Atlas Venture Associates Opportunity I, LLCSee remarks
- Atlas Venture Associates X, LLC10% Owner
- ATLAS VENTURE ASSOCIATES X, L.P.10% Owner
- Atlas Venture Fund X, L.P.10% Owner
- Atlas Venture Opportunity Fund I, L.P.See remarks
- Avidity Partners Management LPDirector
- Beetham Thomas W.See Remarks
- BONNEY MICHAEL WDirector
Tickers
Addresses
business
7 TIMES SQUARE 43RD FLOOR
NEW YORK, NY, 10036
mailing
7 TIMES SQUARE 43RD FLOOR
NEW YORK, NY, 10036
Former names
- Magenta Therapeutics, Inc.2023-09-08
Same industry